Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Hormone Therapy
- Chemotherapy and Radiotherapy
- Palliative Care
- Immunotherapy
- Endoscopy Methods
- Radiological Techniques and Scans
- Chemoprevention
- Gynecological Cancers
Abstract
Citation: Clin Oncol. 2018;3(1):1440.DOI: 10.25107/2474-1663.1440
A Study of a Serious Game for Adolescents and Young Adults with Leukemia
Al-Anazi WK, Alsuhebah AM, Estanislao A, Al-Jasser AM, Al-Hashmi H, Al-Anazi KA
College of Computer and Information Sciences, Prince Sultan University, Riyadh, Saudi Arabia
Department of Hematology and Hematopoietic Stem Cell Transplantation, King Fahad Specialist Hospital, Dammam,Saudi Arabia
Department of Microbiology, Riyadh Regional Laboratory, Riyadh, Saudi Arabia
*Correspondance to: Al-Anazi KA
PDF Full Text Review Article | Open Access
Abstract:
Serious games sparked the possibility of promoting interactive technology in healthcare sector. The design of serious games relies heavily on the experience of the targeted users. The aim of this study is to design and evaluate suitable mechanics of a serious game for adolescents and young adults with leukemia in Saudi Arabia. The study followed usability testing approach by evaluating low-fidelity and high-fidelity prototypes. This study showed that the suitable mechanics in serious game design for adolescents and young adults with leukemia were: mechanics of interaction and play experience comprising of the story, different levels, and characters; mechanics of integrating knowledge and learning including brief dialogues and alerts; and mechanics concerning patients' conditions and constraints consisting of relaxing sound effects and pausing option.
Keywords:
Serious Games; Usability Testing; Adolescents and Young Adults; Leukemia; Saudi Arabia
Cite the Article:
Al-Anazi WK, Alsuhebah AM, Estanislao A, Al-Jasser AM, Al-Hashmi H, et al. A Study of a Serious Game for Adolescents and Young Adults with Leukemia. Clin Oncol. 2018; 3: 1440.